These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 6194396)

  • 1. Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation: carcinoembryonic antigen (CEA) and alphafetoprotein (AFP) as tumor markers of the liver.
    Barroso A; Alpert E
    Lab Res Methods Biol Med; 1983; 7():153-7. PubMed ID: 6194396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers for hepatoma and carcinoma of biliary tract].
    Higashino K
    Rinsho Byori; 1985 Aug; 33(8):861-71. PubMed ID: 2416966
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
    Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
    Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of tumor markers in clinical oncology].
    Gericke D; Drahovsky D
    Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumor markers of hepatocellular carcinoma with special reference to diagnostic efficacy of combination of these markers and relation to its stages].
    Sawabu N; Wakabayashi T; Ozaki K; Toya D; Yoneshima M
    Gan No Rinsho; 1983 May; 29(6):672-7. PubMed ID: 6192267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer].
    Shi X; Zhou Y; Xia L
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):437-9. PubMed ID: 10920938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma].
    Iwamoto I; Furukawa M; Ito S; Nakata T; Tanigawa M; Koga Y; Magari Y
    Gan No Rinsho; 1988 Feb; 34(2):208-12. PubMed ID: 2450213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5'-Nucleotide phosphodiesterase isozyme-V in hepatocellular carcinoma and other liver diseases.
    Fujiyama S; Tsude K; Sakai M; Sato T
    Hepatogastroenterology; 1990 Oct; 37(5):469-73. PubMed ID: 1701410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-fetoprotein, carcinoembryonic antigen and various biochemical tests in patients with tumorous and inflammatory liver diseases.
    Weber P; Weberová D; Martínek K
    Neoplasma; 1988; 35(5):605-13. PubMed ID: 2464143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When is a tumor marker a laboratory test?
    Galen RS
    Ann Clin Lab Sci; 1977; 7(1):51-6. PubMed ID: 65149
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroxine-binding globulin as a marker of liver tumors.
    Terui S; Moriya Y; Yamamoto H; Koyama Y
    Cancer Detect Prev; 1987; 10(5-6):371-8. PubMed ID: 2436781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcino-fetal antigens].
    Endo Y
    Nihon Rinsho; 1996 Jun; 54(6):1499-504. PubMed ID: 8691600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nonspecific tumor markers in hepatocellular carcinoma].
    Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical detection of alpha-fetoprotein, carcinoembryonic antigen, and ferritin in formalin-paraffin sections from hepatocellular carcinoma.
    Imoto M; Nishimura D; Fukuda Y; Sugiyama K; Kumada T; Nakano S
    Am J Gastroenterol; 1985 Nov; 80(11):902-6. PubMed ID: 2413756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of six tumor markers (ferritin, CEA, TPA, AFP, PAP, gamma-Sm) in serum in patients with urogenital malignancies].
    Koizumi F; Nakamura E; Kawamura T; Ishimori A; Hoshi S; Matsuda S
    Rinsho Byori; 1986 Sep; 34(9):1053-8. PubMed ID: 2432295
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic value of 5'-nucleotide phosphodiesterase isozyme-V for detection of liver metastasis in patients with gastro-intestinal cancer.
    Tomoda H; Furusawa M; Ichino M
    Jpn J Clin Oncol; 1983 Jun; 13(2):353-60. PubMed ID: 6310182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory findings in tumor patients. II].
    Wolff J; Anger G
    Z Arztl Fortbild (Jena); 1980 May; 74(10):469-73. PubMed ID: 6158804
    [No Abstract]   [Full Text] [Related]  

  • 18. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
    Torzilli G; Makuuchi M; Ferrero A; Takayama T; Hui AM; Abe H; Inoue K; Nakahara K
    Hepatogastroenterology; 2002; 49(45):740-5. PubMed ID: 12063982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer.
    Farinati F; Varnier M; Piccoli A; Caldironi MW; Zotti S; Plebani M; Di Mario F; Naccarato R
    J Med; 1986; 17(5-6):347-55. PubMed ID: 2438364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Timor J; Thambyrajah V
    Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.